PDL BioPharma, Inc. Long Term Assets (Tax, Deferred)

Long Term Assets (Tax, Deferred) of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long Term Assets (Tax, Deferred) growth rates and interactive chart.


Highlights and Quick Summary

  • Long Term Assets (Tax, Deferred) for the quarter ending December 30, 2018 was $1.54 Million (a -40.53% decrease compared to previous quarter)
  • Year-over-year quarterly Long Term Assets (Tax, Deferred) decreased by -75.12%
  • Annual Long Term Assets (Tax, Deferred) for 2018 was $1.54 Million (a -36.72% decrease from previous year)
  • Annual Long Term Assets (Tax, Deferred) for 2017 was $2.43 Million (a -87.37% decrease from previous year)
  • Annual Long Term Assets (Tax, Deferred) for 2016 was $19.3 Million (a 19.08% increase from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long Term Assets (Tax, Deferred) of PDL BioPharma, Inc.

Most recent Long Term Assets (Tax, Deferred)of PDLI including historical data for past 10 years.

Interactive Chart of Long Term Assets (Tax, Deferred) of PDL BioPharma, Inc.

PDL BioPharma, Inc. Long Term Assets (Tax, Deferred) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2018 $1.54 $2.59 $1.54
2017 $2.43 $6.19 $21.62 $11.66 $2.43
2016 $19.26 $24.23 $25.71 $26.36 $19.26
2015 $16.17 $36.5 $35.6 $34.92 $16.17
2014 $33.8 $25.1 $17.4 $17.37 $33.8
2013 $6.7 $3.53 $3.61 $6.7
2012 $4.55 $6.16 $4.85 $6.65 $4.55
2011 $11.48 $14.03 $24.86 $24.6 $11.48
2010 $22.62 $16.92 $22.62

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.